Skip to main content
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1981 Feb;19(2):253–255. doi: 10.1128/aac.19.2.253

Cefoxitin disposition during peritoneal dialysis.

W L Greaves, J H Kreeft, R I Ogilvie, G K Richards
PMCID: PMC181403  PMID: 7347560

Abstract

The pharmacokinetic disposition of 2 g of cefoxitin administered intravenously over 30 min was determined in six patients undergoing continuous ambulatory peritoneal dialysis for chronic renal failure. During the 6-h dialysate dwell time after the drug infusion, the mean apparent volume of distribution for cefoxitin was 0.267 liter/kg (range, 0.201 to 0.325 liter/kg), and the mean elimination t1/2 from plasma was 7.8 h (range, 5.5 to 13.1 h). The peritoneal clearance, averaging 1.51 ml/min (range, 0.58 to 2.35 ml/min), was only 7.4% of the mean plasmas clearance of cefoxitin. Cefoxitin clearance was reduced in patients with renal failure and was not increased by peritoneal dialysis.

Full text

PDF
253

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andriole V. T. Pharmacokinetics of cephalosporins in patients with normal or reduced renal function. J Infect Dis. 1978 May;137 (Suppl):S88–S99. doi: 10.1093/infdis/137.supplement.s88. [DOI] [PubMed] [Google Scholar]
  2. Fillastre J. P., Leroy A., Godin M., Oksenhendler G., Humbert G. Pharmacokinetics of cefoxitin sodium in normal subjects and in uraemic patients. J Antimicrob Chemother. 1978 Jul;4(B):79–83. doi: 10.1093/jac/4.suppl_b.79. [DOI] [PubMed] [Google Scholar]
  3. Garcia M. J., Dominguez-Gil A., Tabernero J. M., Bondia Román A. Pharmacokinetics of cefoxitin in patients undergoing hemodialysis. Int J Clin Pharmacol Biopharm. 1979 Aug;17(8):366–370. [PubMed] [Google Scholar]
  4. Humbert G., Fillastre J. P., Leroy A., Godin M., Van Winzum C. Pharmacokinetics of cefoxitin in normal subjects and in patients with renal insufficiency. Rev Infect Dis. 1979 Jan-Feb;1(1):118–126. doi: 10.1093/clinids/1.1.118. [DOI] [PubMed] [Google Scholar]
  5. Oreopoulos D. G. Continuous ambulatory peritoneal dialysis in Canada. Can Med Assoc J. 1979 Jan 6;120(1):16–19. [PMC free article] [PubMed] [Google Scholar]
  6. Popovich R. P., Moncrief J. W., Nolph K. D., Ghods A. J., Twardowski Z. J., Pyle W. K. Continuous ambulatory peritoneal dialysis. Ann Intern Med. 1978 Apr;88(4):449–456. doi: 10.7326/0003-4819-88-4-449. [DOI] [PubMed] [Google Scholar]
  7. Rubin J., Rogers W. A., Taylor H. M., Everett E. D., Prowant B. F., Fruto L. V., Nolph K. D. Peritonitis during continuous ambulatory peritoneal dialysis. Ann Intern Med. 1980 Jan;92(1):7–13. doi: 10.7326/0003-4819-92-1-7. [DOI] [PubMed] [Google Scholar]
  8. Trollfors B., Norrby R., Kristianson K., Nilsson N. J. Effects on renal function of treatment with cefoxitin alone or in combination with furosemide. Scand J Infect Dis Suppl. 1978;(13):73–77. [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES